A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer
暂无分享,去创建一个
K. Malloy | A. Eisbruch | T. Carey | C. Bradford | G. Wolf | D. Chepeha | M. Prince | J. Moyer | F. Worden | S. Mclean | A. Shuman | Lili Zhao | P. Swiecicki | M. Spector | A. Sacco | I. Dobrosotskaya | E. McKean | E. Belile